What Researchers Did
Researchers compared hyperbaric oxygen therapy with conventional treatment for virus-associated hemorrhagic cystitis in 16 patients after allogeneic hematopoietic stem cell transplantation.
What They Found
All 8 patients receiving hyperbaric oxygen therapy achieved complete remission within a median of 14.5 days, compared to 5 out of 8 (62.5%) patients receiving conventional therapy. Furthermore, transplant-related mortality at day 100 was significantly lower in the hyperbaric oxygen group (0%) compared to the conventional therapy group (14.2%, P < 0.05).
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The small sample size of only 16 patients limits the generalizability of these findings.